생약독화 백신 시장 : 제품 유형별, 기술별, 적응증별, 투여 방법별, 연령층별, 유통 채널별, 지역별

Global Life Attenuated Vaccines Market is estimated to be valued at US$ 29.50 Bn in 2025 and is expected to reach US$ 63.21 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.5% from 2025 to 2032.

Figure. Life Attenuated Vaccines Market Share (%), By Region 2025

Life attenuated vaccines use weakened or attenuated live microorganisms or pathogens to trigger immunity. When administered to a patient, these vaccines mimic a natural infection but do not cause the disease. Common life attenuated vaccines include measles, mumps, rubella (MMR), varicella, rotavirus, and yellow fever vaccines. Growing awareness regarding preventive healthcare and rising immunization programs worldwide are expected to support the growth of this market over the forecast period.

Market Dynamics:

Increasing investments by government bodies in immunization programs across developing nations are expected to drive the market growth during the forecast period. Moreover, rising incidence of various diseases, such as measles, mumps, and rubella, is further propelling the demand for life attenuated vaccines. However, high costs associated with vaccine development and stringent regulations for approval are the major factors anticipated to restrain the market growth. On the flip side, ongoing research & development activities to develop vaccines for new diseases and approval of newer attenuated vaccines are likely to present attractive growth opportunities for the players in the market.

Key Features of the Study:

This report provides in-depth analysis of the global life attenuated vaccines market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global life attenuated vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include GlaxoSmithKline plc, Merck & Co., Pfizer, Inc., Astellas Pharma Inc., Johnson & Johnson, CSL Limited, Emergent BioSolutions, Inc., MedImmune, LLC, Sanofi, Serum Institute of India Pvt. Ltd., Bharat Biotech, Takeda Pharmaceutical Company, Novartis AG, BioNTech SE, and Sinovac Biotech Ltd.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global life attenuated vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global life attenuated vaccines market

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Bacterial
  • Viral
• Technology Insights (Revenue, USD Bn, 2020 - 2032)
  • Classical Techniques
  • Live Attenuation
  • Inactivated/Killed
  • Advanced Techniques
  • Recombinant DNA Technology
  • Viral Vector Technology
• Indication Insights (Revenue, USD Bn, 2020 - 2032)
  • Tuberculosis
  • Measles
  • Rotavirus
  • Yellow Fever
  • Oral Polio
  • Others
• Mode of Administration Insights (Revenue, USD Bn, 2020 - 2032)
  • Injectable
  • Intranasal
  • Oral
  • Others
• Age Group Insights (Revenue, USD Bn, 2020 - 2032)
  • Pediatric Vaccines
  • Adult Vaccines
  • Geriatric Vaccines
• Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • GlaxoSmithKline plc
  • Merck & Co.
  • Pfizer, Inc.
  • Astellas Pharma Inc.
  • Johnson & Johnson
  • CSL Limited
  • Emergent BioSolutions, Inc.
  • MedImmune, LLC
  • Sanofi
  • Serum Institute of India Pvt. Ltd.
  • Bharat Biotech
  • Takeda Pharmaceutical Company
  • Novartis AG
  • BioNTech SE
  • Sinovac Biotech Ltd.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Life Attenuated Vaccines Market, By Product Type
  • Global Life Attenuated Vaccines Market, By Technology
  • Global Life Attenuated Vaccines Market, By Indication
  • Global Life Attenuated Vaccines Market, By Mode of Administration
  • Global Life Attenuated Vaccines Market, By Age Group
  • Global Life Attenuated Vaccines Market, By Distribution Channel
  • Global Life Attenuated Vaccines Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Life Attenuated Vaccines Market, By Product Type, 2025-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Bacterial
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Viral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Life Attenuated Vaccines Market, By Technology, 2025-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Classical Techniques
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Live Attenuation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Inactivated/Killed
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Advanced Techniques
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Recombinant DNA Technology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Viral Vector Technology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Life Attenuated Vaccines Market, By Indication, 2025-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Tuberculosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Measles
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Rotavirus
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Yellow Fever
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Oral Polio
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Life Attenuated Vaccines Market, By Mode of Administration, 2025-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Injectable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Intranasal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Life Attenuated Vaccines Market, By Age Group, 2025-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pediatric Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Adult Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Geriatric Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Life Attenuated Vaccines Market, By Distribution Channel, 2025-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Life Attenuated Vaccines Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Mode of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Mode of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Mode of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Mode of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa

11. Competitive Landscape

• GlaxoSmithKline plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck & Co.
• Pfizer, Inc.
• Astellas Pharma Inc.
• Johnson & Johnson
• CSL Limited
• Emergent BioSolutions, Inc.
• MedImmune, LLC
• Sanofi
• Serum Institute of India Pvt. Ltd.
• Bharat Biotech
• Takeda Pharmaceutical Company
• Novartis AG
• BioNTech SE
• Sinovac Biotech Ltd.

12. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

13. References and Research Methodology

• References
• Research Methodology
• About us